Increased propensity for calcium phosphate kidney stones with topiramate use
Authors:
- Naim M MaaloufNMNaim M Maalouf
- Khashayar SakhaeeKSKhashayar Sakhaee
- 18 September 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 6 (5) , 547-557
Abstract
Topiramate (TPM) is a neuromodulatory agent that was initially approved as an antiepileptic drug and is increasingly used in the treatment of a number of neurological and metabolic disorders. Among its various pharmacological actions, TPM has been shown to inhibit the activity of specific carbonic anhydrase enzymes in the kidney. This action is associated with the development of metabolic acidosis, hypocitraturia, hypercalciuria and elevated urine pH, leading to an increased risk of kidney stone disease. Despite the cautionary note in the package insert of TPM, the extent of these complications has not been fully explored. Few prescribing physicians are aware of these complications, underscoring the need for improved surveillance. Because the drug is among the most frequently prescribed agents in the US, more controlled studies are required to determine the prevalence of kidney stone disease among TPM users, and the optimal approach to prevent and treat nephrolithiasis in these individuals.Keywords
This publication has 91 references indexed in Scilit:
- Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose–thioureido tailsBioorganic & Medicinal Chemistry Letters, 2007
- Carbonic Anhydrase Inhibitors. DNA Cloning, Characterization, and Inhibition Studies of the Human Secretory Isoform VI, a New Target for Sulfonamide and Sulfamate InhibitorsJournal of Medicinal Chemistry, 2006
- Carbonic Anhydrase Inhibitors: Clash with Ala65 as a Means for Designing Inhibitors with Low Affinity for the Ubiquitous Isozyme II, Exemplified by the Crystal Structure of the Topiramate Sulfamide AnalogueJournal of Medicinal Chemistry, 2006
- Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled studyInternational Journal of Obesity, 2006
- Topiramate in migraine prophylaxisNeurological Sciences, 2005
- Effect of antiepileptic drug polytherapy on crystalluriaPediatric Neurology, 2005
- Clinical implications of abundant calcium phosphatein routinely analyzed kidney stonesKidney International, 2004
- Acid and mineral balances and bone in familial proximal renal tubular acidosisKidney International, 2000
- The first anionic sulfonamide-binding zinc(II) complexes with a macrocyclic triamine: chemical verification of the sulfonamide inhibition of carbonic anhydraseJournal of the American Chemical Society, 1992
- The Activity of Sulfonamides and Anions Against the Carbonic Anhydrases of Animals, Plants, and BacteriaAnnual Review of Pharmacology and Toxicology, 1983